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Background: Reduced renal function in chronic kidney disease (CKD) necessitates appropriate dose alterations to 
avoid drug accumulation.  
Objectives: The main objective of the study was to determine the prevalence of inappropriate antibiotic dosing in 
patients with CKD in the largest referral hospital in eastern Africa. Variables associated with inappropriate dosing 
were identified.  
Methods: The design was a retrospective review of patients’ records. The study population was adult patients, with 
CKD admitted between January, 2006 and December, 2010.  Data was abstracted from patient files. Logistic regression 
was used to determine variables associated with appropriate antibiotic dosing.   
Results: Ceftriaxone and amoxicillin-clavulanic acid were the most frequently prescribed antibiotics. Dose adjustment 
was required for 379 (59.9%) antibiotic prescriptions. Of these, 105 doses (27.7% [95% CI: 23.2 – 32.2%]) were 
appropriate and 274 (72.3% [95% CI 67.8 – 76.8%]) were inappropriate.  The resultant dosing errors were: 271 
(98.9%) and 3 (1.1%) cases of over and under dosing respectively. Key explanatory variables for appropriate dosing 
were: stage of renal disease (adjusted odds ratio (OR) 0.159 [95% CI: 0.082, 0.309]); administration; (adjusted OR 
1.724 [95% CI:1.185, 2.508]); and treatment with amoxicillin-clavulanic acid (adjusted OR 0.101 [95% CI 0.024, 
0.420].  
Conclusion: Antibiotic doses in patients with CKD were often inappropriate.   
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1. Introduction 
Irrational, improper or inappropriate antibiotic use 
consists of improper practices such as   unwarranted 
use with no clear indication, incorrect choice for a given 
infection, improper timing and improper or 
unnecessary combinations (Kunin et al, 1973; Ozkurt et 
al, 2005).Incorrect antibiotic dosing, also termed 
inappropriate dosing, is the administration of doses that 
are above or below the recommended dosage and 
frequency (Seyler et al, 2011). An inadequate dosing 
regimen is failure to attain the minimum therapeutic 
concentration in plasma (Seyler et al, 2011). Dose 
adjustment is the practice of changing a dose on the 
basis of patient or disease related factors such as body 
mass index or renal function.  It may be done correctly 
or incorrectly. Patients with chronic kidney disease 
(CKD) are particularly prone to treatment failure and 
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adverse drug reactions resulting from administration of 
inappropriate doses of antibiotics (Seyler et al, 2011). 
Kidney diseases are a global public health problem 
(Levey et al, 2007).  Sub-Saharan African countries have 
an increasing burden of chronic kidney renal disease. 
For instance, Sumaili et al (2009), found that the 
prevalence of chronic kidney disease (CKD) among 
Congolese study subjects was 36%.  In Kenya, patients 
with reduced renal function are often encountered in 
clinical practice (Wools-Kaloustian, 2007; Ogeng’o et al, 
2011).  
Decreased renal function affects the pharmacokinetic 
disposition as well as the pharmacodynamic effects of 
drugs. Careful dose adjustment and therapeutic drug 
monitoring are essential in patients with renal 
insufficiency to prevent accumulation of administered 
drugs and/or toxic metabolites (Myrna et al, 2007; 
Hassan et al, 2009). Appropriate dose adjustment 
reduces the incidence of adverse drug reaction, 
improves treatment success and reduces hospital 
admission and even mortality.   It reduces costs 
associated with drug related toxicity and resultant 
increased hospital stay (Bonapace et al, 2002). 
Drugs that are largely excreted by the kidney as active 
compounds require dose adjustment (Verbeeck and 
Musuamba, 2009). Dose adjustment with CKD is 
dependent on the degree of renal impairment and the 
half life of the drug (Swan and Bennet,1992).Patients 
with CKD are particularly prone to developing sepsis 
and other infections. Antibiotics are therefore inevitably 
widely used by renal patients.  For most antibiotics, the 
loading dose may not require adjustment but the 
maintenance dose may need adjustment (Myrna et al, 
2007; Hassan et al, 2009). 
There is paucity of literature regarding the practice of 
antibiotic dose adjustment in Kenyan patients with CKD.  
This study was conducted to evaluate the practice of 
antibiotic dose adjustment for patients with chronic 
kidney in Kenyatta National Hospital which is the 
largest teaching and referral hospital in Eastern Africa.  
Patients with CKD are referred from all over the country 
for dialysis and follow up.  The practices in this referral 
hospital influence practice in the rest of the country and 
in the region. The hospital has no written protocol for 
antibiotic drug prescribing for patients with CKD.  The 
main objective of the study was to determine the 
proportion of patients with CKD who received 
inappropriate doses of antibiotics as per standard 
international guidelines for dose adjustment.  Drug and 
patient related explanatory variables for inappropriate 
dosing were also identified. 
2.  Methods 
2.1 Study design and population 
The design was a cross sectional study that involved a 
retrospective review of patient files. It was conducted in 
Kenyatta National Hospital (KNH) which is the largest 
referral, teaching and research hospital in East Africa.  
The hospital receives approximately 5 new patients 
with CKD every week.   The patients were drawn from 
two clinical sites within the hospital: the medical wards 
and the specialized renal unit of KNH. The study 
population was adult patients aged 18 years and above 
with a diagnosis of CKD and admitted in the hospital 
between January, 2006 to December, 2010.   
2.2  Inclusion criteria 
The inclusion criteria were: diagnosis of CKD, an 
antibiotic prescription and a documented serum 
creatinine concentration at the time the antibiotic 
prescription was written.   
2.3  Sampling 
Sample size was calculated using the equation for cross 
sectional studies described by Browner et al (2007).  
The expected prevalence of inappropriate antibiotic 
dose s was 75 % which was the figure reported by 
Arlicot et al (2007).  Alpha was set at 0.05 and the width 
of the confidence interval was 0.10. The calculated 
sample size was adjusted upwards by 10% to allow for 
missing information in the files. The targeted minimal 
sample size was 317.  
A list of all patients with a diagnosis of CKD seen 
between January 2006 and December 2010 was 
obtained from the Medical Records department.  From 
the list, simple randomization with replacement 
(Altaman and Bland 1999) was performed to obtain a 
sample of 500 files.  The files were selected by picking a 
paper a pile of papers that each a file. The pile was 
shuffled before each draw.   All files that met the 
inclusion criteria were included in the study. 
2.4 Data collection  
A pre-tested data collection form was used to abstract 
the following information from patient files: patient 
demographics, co-morbidities and serum creatinine 
concentration. Data was also collected on   antibiotics 
prescribed, their   doses, frequency and durationof 
administration. For patients who had more than three 
prescriptions during the study period, data abstraction 
was restricted to the latest three antibiotic 
prescriptions.  Prescriptions were first assessed to 
determine if they contained antibiotics for drugs for 
which dose adjustment is routinely required in CKD. 
Those that contained drugs that did not require dose 
adjustment were not analyzed further.  
The prescribed antibiotic doses were compared with 
those that are recommended in the dosing guidelines 
for adults with CKD by the American College of 
Physicians (Aronoff, 2007). For drugs not listed in this 
guideline, the recommendations of the British National 
Formulary were used to judge the appropriateness of 
dose adjustment (British National Formulary, 2010).  
The guidelines required calculation of the estimated 
glomerular filtration rate (eGFR) to determine the 
appropriate dose. 
Serum creatinine levels, age and sex were used to 
calculate eGFR using the Modification of Diet in Renal 
Disease four variable (MDRD) equation (National 
Kidney Foundation, 2002;Coreshet al, 2002).Disparities 
between the recommended and prescribed dose were 
noted.  
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Figure 1: Consort diagram of selection of adult patient with chronic kidney disease for inclusion in study 
 
2.5  Case definition 
Where a prescription had more than one antibiotic, 
each was treated as a separate antibiotic prescription. 
Appropriate dose was defined as the agreement of the 
prescribed dose and frequency with the guideline 
recommendations taking into consideration the degree 
of comprised renal function. Where there was a 
disparity in the prescribed and calculated doses, the 
prescribed dose was considered to be inappropriate.   
An overdose was defined a dose or frequency of 
administration that was greater than that calculated on 
the basis on the guideline recommendations.  An under 
dose was defined a dose or frequency of administration 
that was less than that calculated on the basis on the 
guideline recommendations. 
2.6 Variables 
The main outcome of interest was appropriateness of 
the antibiotic dose.  The independent variables included 
patient demographics, antibiotic prescribed, severity of 
renal disease, hospital unit where the prescription was 
generated, prescriber trait, concurrent medical 
condition, duration of therapy and whether the patient 
is on dialysis or not and the dialysis type. 
2.7  Data analysis 
Data analysis was conducted using STATA version 9 
statistical software. Shapiro-Wilk test for deviation of 
continuous variables from normality showed that all the 
continuous variables did not follow normal distribution. 
The medians and interquartile ranges were therefore 
reported.   
Proportions were used to summarize categorical 
variables.  Patient, disease and drug related variables of 
prescriptions with inappropriate and appropriate doses 
were compared.  
Pearson’s Chi-square test was used to test for the 
presence of association between categorical variables 
and compare their distribution across groups. The two 
sample Wilcoxon rank-sum test was used for inferential 
data analysis of continuous variables.  
Logistic regression was carried out to adjust for 
cofounding.  Manual forward stepwise model building 
was done to identify the most important risk factors for 
prescriptions with inappropriate antibiotic doses. P 
values of less than 0.05 were considered to be 
statistically significant.  
1199 CKD patients identified at 
the records department 
500 files were randomly 
selected  
473 files availed 
27 files could not 
be traced 
Excluded for the following 
reasons 
• 133 files had no antibiotics 
prescriptions 
• 18 were < 18 years old 
• 6 had no  CKD diagnosis 
• 2 had undergone kidney 
transplant 
314 files were finally 
used for the study 
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2.8 Ethical considerations 
 Permission to carry out the research was obtained from 
the KNH/University of Nairobi Research and Ethics 
Committee as the letter of approval of 11th of March, 
2011, reference number KNH-ERC/A/52. Information 
regarding the patient identity was kept confidential by 
the using the files within the confines of the hospital, 
limiting access to the files to the investigators and 
exclusion of patient identifying information such as 
patient names from the data collection form. Study 
numbers were assigned to each patient. All the filled 
data collection forms was filed and stored in lockable 
drawer. 
 
Table 1:  Demographic characteristics and baseline renal function of the study participants 
Variable n (%) Variable n (%) 
Sex  Baseline Stage of CKDa  
Female 134 (42.7%) 1 3 (1.0%) 
Male 180 (57.3%) 2 6 (1.9%) 
  3 14 (4.5%) 
Age group  4 29 (9.2%) 
≥ 45 years       166 (52.9%) 5 262 (83.4%)  
Below 45 years 148 (47.1%)   
  Cause of CKDa  
Age (median, years) 46 [32, 60], n=313 Unknown 62 (20%) 
  Diabetes mellitus 32 (10.2%) 
Marital status  Hypertension 50 (15.9%) 
  Diabetes and hypertension 35 (11.1%) 
Married 249 (79.3%) Primary glomerular disease 57 (18.2%) 
Single  63 (20.1%) HIV associated nephropathy 27 (8.6%) 
Missing 2 (0.6%) Obstructive uropathy 45 (14.3%) 
  Drug induced 2 (0.6%) 
Highest level of education Other 4 (1.3%) 
No education 34 (10.8%)   
Primary School 118 (37.6%)   
Secondary School 104 (33.1%) Co-morbidity  
Tertiary 38 (12.1%)   
Missing 20 (6.4%) None 46 (14.7%) 
  Diabetes mellitus 82 (26.1%) 
Employment  Hypertension  115 (36.6%) 
  HIV/AIDSb 31 (9.9%) 
Unemployed 193 (61.5%) Heart disease 11 (3.5%) 
Employed 50 (15.9%) BPHc 12 (3.8%) 
Self employed 67 (21.3%) Prostate cancer 5 (1.6%) 
Missing 4 (1.3%) Cervical cancer 3 (1%) 
  Breast cancer 1 (0.3%) 
Weight (kg) 62 [56, 70], n=59 Others 8 (2.6%) 
aChronic Kidney Disease;  bHuman Immunodeficiency Virus/Acquired Immunodeficiency Syndrome; c Benign Prostrate Hypertrophy. 
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3.  Results  
3.1 Baseline characteristics of the study 
participants 
The Medical Records Department provided a list of 
1199 patients who had a diagnosis of CKD over the 4 
year study period. Five hundred patients were 
randomly selected from this list.  From the list, 473 files 
were availed for the study. Of these, 314 met the 
eligibility criteria and were used in the study.  Of the 
remaining files, 133 files had no antibiotic prescriptions 
within the study period, 18 of the files were for patients 
aged below 18 years of age, 6 had no documented 
diagnosis of CKD and 2 had had kidney transplantation 
(Figure 1). 
The baseline demographic characteristics of the 
patients are presented in Table 1.  The median age at 
diagnosis of CKD in the study population was 46 years. 
There were slightly more male (n=180, 57.3%) than 
female patients.  There was limited data on weight with 
only 59 entries at baseline.  
Most of the patients were married (n=249, 79.3%) and 
142 (45.2%) had attained secondary or tertiary 
education. 
3.2 Patterns of antibiotic prescription in patients 
with chronic kidney disease 
Out of the 473 files obtained from the records 
department, 18 belonged to patients aged below 18 
years and were therefore excluded from the study.  The 
rest of the files number belonged to adult patients. Out 
of 455 adult patients, 314 (69.0%) had a prescription 
for an antibiotic.  Some patients had received more than 
one antibiotic prescription during the study period. 
There were a total of 639antibiotic prescriptions.  
Twenty four different types of antibiotics were 
prescribed. The proportions of the different types of 
antibiotics prescribed are presented in Figure 2.The 
most frequently prescribed drugs were ceftriaxone 
(n=145, 22.7%) and amoxicillin-clavulanic acid (n=131, 
20.5%).  Five prescriptions (0.78%) had nitrofurantion 
which is contraindicated in patients with CKD. 
Table 2 presents the indication, duration, frequency 
and routes of antibiotic administration.  The clinical 
sites where the prescribing was done as well as selected 
renal parameters at the time the prescription was 
generated are presented.  All patients seen in the renal 
unit had stage 5 disease and most of them (97.1%) were 
on dialysis. The most common indication was 
respiratory tract infection (n= 104, 16.3%).  There was 
no written indication for antibiotic use for 297 (46.5%) 
prescriptions. Patients seen in the clinical wards had 
less severe renal disease (P<0.000).Most antibiotics 
were administered intravenously (n=485, 75.9%).  Most 
antibiotics were administered 12 hourly (twice daily) or 
8 hourly (three times daily).  There was no written 
duration of administration for 224 (35.1%) 
prescriptions. 
3.3 Appropriateness of doses of antibiotics 
prescribed to patients with chronic kidney disease  
The prescriptions were scrutinized to determine if they 
contained antibiotics for which dose adjustment is not 
routinely required.   Five prescriptions (0.78%) had 
nitrofurantion which is contraindicated in patients with 
CKD and therefore were not evaluated. Out of the 634 
prescriptions that were evaluated, 379 (59.9%) had 
antibiotics for which dose adjustment is routinely 
required and 255(40.1%) did not require dose 
adjustment. 
 
*Others: Gentamicin (1.3%); Amoxicillin (1.1%); Cotrimoxazole (1.1%); Amikacin (0.8%); Nitrofurantion (0.8%); 
Imipenem/cilastatin (0.8%); Levofloxacin (0.8%); Linezolid (0.5%); Doxycycline (0.3%); Clindamycin (0.2%); 
Piperacillin/tazobactam (0.2%); and Erythromcyin (0.2%) 
Figure 2: Antibiotics prescribed to patients with chronic kidney disease in Kenyatta National Hospital (N=639) 
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Table 2: Patterns of antibiotic prescribing and renal parameters of patients with chronic kidney disease at Kenyatta 
National Hospital 
aRTI - Respiratory Tract Infection , bGFR - Glomerular Filtration Rate, cCNS – Central Nervous System 
3.3 Appropriateness of doses of antibiotics 
prescribed to patients with chronic kidney disease  
The prescriptions were scrutinized to determine if they 
contained antibiotics for which dose adjustment is not 
routinely required.    
Five prescriptions (0.78%) had nitrofurantion which is 
contraindicated in patients with CKD and therefore 
were not evaluated. Out of the 634 prescriptions that 
were evaluated, 379 (59.9%) had antibiotics for which 
dose adjustment is routinely required and 255(40.1%) 
did not require dose adjustment. 
Out of the 379 prescriptions for which dose adjustment 
is routinely required, 105 doses (27.7%, (95% CI 23.2 – 
32.2%) were appropriate according to the degree of 
renal insufficiency and 274 (72.3%) were 
inappropriate.  The errors that resulted from 
prescribing inappropriate doses were: 271 (98.9%) 
cases of overdose and only 3(1.1%) cases of under 
dosing.  
According to the dosing guidelines for adults with CKD 
by the American College of Physicians (Aronoff, 2007), 
seven of the prescribed antibiotics that did not require 
dose adjustment were: ceftriaxone (n=145, 22.9%); 
metronidazole (n=53, 8.4%); flucloxacillin (n=20, 3%); 
Indications for the antibiotic        n (%) Clinical setting where the prescription was 
generated                             n (%) 
None documented 297 (46.5) General Wards 533 (83.4%) 
RTIa 104 (16.3%) Renal Unit 105 (16.4%) 
Catheter site infection 14 (2.2%) Missing  1(0.2%) 
Sepsis 85 (13.3%)   
Urinary Tract Infection  
Gastroenteritis 
51 (8.0%) 
46 (7.2%) 
Serum Creatinine 
(µmol/L)  
Median (IQR), 
778 
 
(434,1141), n=639 
Surgical prophylaxis 9 (1.4%) eGFRb(ml/min/1.73m2)  
Median (IQR), n 
7.486  
(4.782, 14.96), n=639 
CNSc infection 3 (0.5%)   
Bone and soft tissue 
infections 
5 (0.8%) Patients on dialysis at the time of prescribing 
Others  25 (3.9%) Not on dialysis 303 (47.4%) 
  On dialysis 336 (52.6%) 
    
Route of drug administration Frequency of administration (times daily) 
Intravenous 485 (75.9%) Start dose 19 (3.0%) 
Oral 152 (23.8%) Once 95 (14.9%) 
Missing 2 (0.3%) Twice 246(38.5%) 
  Thrice 193(30.2%) 
Duration of antibiotic administration (days) Four  55 (8.6%) 
Not written 224 (35.1%) 5 to 10  30 (4.7%) 
1 to 4  18 (2.8%) Missing 1 (0.2%) 
5 179 (28.0%)   
7 163(25.5%)   
9 to 12 34 (5.3%)   
14 14 (2.2%)   
15  to 21  3 (0.5%)   
28  to 30  2 (0.3%)   
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linezolid (n=3, 0.5%); doxycycline (n=2, 0.3%); 
erythromycin (n=1, 0.2%); and clindamycin (n=1, 
0.3%). 
The antibiotics for which dose adjustment is routinely 
required are listed in Table 3. Amoxycillin-clavulanic 
acid, ciprofloxacin and benzyl penicillin were the most 
frequently prescribed antibiotics that required dose 
adjustment.  Table 3 includes some antibiotics that 
were administered as single loading doses, and 
therefore, dose adjustment was not required. 
Cefuroxime axetil which is the oral formulation of 
cefuroxime does not routinely require adjustment.   
All patients treated will levofloxacin (n=5), 
cotrimoxazole (n=7) and piperacillin/tazobactam (n=1) 
received inappropriate doses.  Over 75% of patients 
treated with amoxicillin-clavulanic acid (118, 91.5%), 
cefuroxime (27, 79.4%), meropenem (9, 75%) and 
amikacin (3, 75%) received inappropriate doses.   
Vancomycin (23, 69.7%) was the only antibiotic for 
which over 50 % of treated patients received the 
appropriate dose.  
About half of the patients treated with benzylpenicillin 
(18, 48.6%) received the appropriate dose. 
 
Table 3: Appropriateness of prescribed doses of antibiotics for which dose adjustment is routinely required in 
patients with chronic kidney disease 
Antibiotic  
Need for dose adjustment* Appropriateness of prescribed doses 
Not 
required 
Adjustment 
required 
Dose not appropriate  
n (%) 
Dose  appropriate 
n (%) 
Aminoglycosides     
Amikacin 1 4 3(75.0%) 1 (25.0%) 
Gentamicin  0 8 5(62.5%) 3(37.5%) 
Betalactams     
Amoxicillin-clavulanic acid 2 129 118(91.5%) 11(8.5%) 
Benzyl penicillin  0 37 19(51.4%) 18(48.6%) 
Amoxicillin  1 6 4(66.7%) 2(33.3%) 
Piperacillin/tazobactam 0 1 1(100%) 0(0.0%) 
Monobactams     
Imipenem/cilastatin 0 5 3(60.0%) 2(40.0%) 
Meropenem 0 12 9(75.0%) 3(25.5%) 
Cephalosporins     
Ceftazidime 0 17 11(64.7%) 6(35.3%) 
Cefuroxime  11 34 27(79.4%) 7(20.6%) 
Fluoroquinolones     
Ciprofloxacin  0 53 33(62.3%) 20(37.7%) 
Norfloxacin 0 10 7(70.0%) 3(30.0%) 
Levofloxacin  0 5 5(100.0%) 0(0.0%) 
Miscellaneous     
Cotrimoxazole 0 7 7(100.0%) 0(0.0%) 
Clarithromycin  0 18 12(70.6%) 6(29.4%) 
Vancomycin 15 33 10(30.3%) 23(69.7%) 
Total  30 () 379(59.9%) 274(72.3%) 105 (27.7%) 
*If a single dose was administrated, dose adjustment was not considered necessary 
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3.4 Risk factors for prescriptions with 
inappropriate antibiotic doses for patients with 
chronic kidney disease 
Table 4 (Supporting information) presents the results 
of bivariable analysis which was carried out to 
determine if there was an association between each of 
the covariates and appropriate dose administration.   
The crude and adjusted odd ratios for the association 
between inappropriate dosing and predictor variables 
are presented in Table 5 (Supporting information). On 
bivariable analysis, the statistically significant 
predictors of appropriateness of the antibiotic dose: 
were dialysis status, severity of renal disease, type of 
antibiotic, frequency and duration of drug 
administration (Table 4, Supporting information).  
Severity of renal disease was measured using three 
parameters: serum creatinine, estimated GFR and the 
CKD stage. All these variables remained significant on 
adjusting for confounding (Table 5, Supporting 
information). The association between age group and 
appropriate dosing was not statistically significant on 
bivariable analysis but was significant on multivariable 
analysis. There was a negative association between 
appropriate antibiotic dose and the following variables: 
stage of renal disease (adjusted OR 0.159 [95% CI: 
0.082, 0.309]) and age below 45 years (adjusted OR 
0.422 [95% CI: 0.198, 0.898]). 
Although the association between dialysis status and 
appropriate antibiotic dose was not statistically 
significant, it is notable that there was a strong negative 
association (adjusted OR 0.458 [95% CI: 0.192, 1.090]). 
Benzylpenicillin was selected as the reference drug 
because a sizeable number of patients were treated 
with this drug and there is a lot of clinical experience 
with use of this drug.  Secondly about equal proportions 
of the patients on benzyl penicillin received appropriate 
and inappropriate doses. The odds of receiving a wrong 
dose of amoxicillin-clavulanic acid were about ten times 
the odds of receiving a wrong dose of benzylpenicillin 
(adjusted OR 0.101 [95% CI: 0.024, 0.420]).The only 
antibiotics for which the odds of receiving a correct 
dose were greater than that of benzylpenicillin were: 
vancomycin; meropenem; imipenem/cilastatin; 
metronidazole and gentamicin. However these findings 
were not statistically significant because of the small 
numbers of patients treated with these drugs.  
There was also a statistically significant positive 
association between the presence of heart disease and 
the correct dose administration. 
4. Discussion  
The key finding of our study is that, only 27.7% of the 
prescribed antibiotic doses were appropriate. A number 
of surveys show that dose adjustment of drugs used by 
patients with CKD is often incorrect and may not be 
done at all (van Dijk et al, 2006; Arlicot et al, 2007; 
Sweileh et al, 2007;  Markota et al, 2009).  These studies 
show a wide variation in the prevalence of 
inappropriate dose administration ranging from 25 to 
68%.  Our study is in agreement with published studies.  
The proportion of inappropriately prescribed 
antibiotics in our study setting (72.3%) was very 
similar to that reported in a study conducted in France 
where prevalence of inappropriate antibiotic dose 
prescribing was at 75% (Salomon et al, 2003).The 
investigators in the French study noted that the 
antibiotics were prescribed according to protocols for 
use in patients with normal renal function. A similar 
practice was observed in our study. A study done in 
South Africa also reported a similar prevalence of 68% 
of inappropriate (Decloedt et al, 2010). 
The problem of inappropriate dose adjustment in renal 
insufficiency seems to be widespread. The key barrier 
to dose adjustment in many clinical settings is a high 
physician and clinical pharmacist workload which 
makes it difficult to attend to detail (Vogtländer et al 
2002). In addition, many clinical centers electronic 
support prescribing systems which have the potential of 
improving prescribing practice (Vogtländer et al 2002). 
The most common error was over dosing because doses 
that were prescribed to patients with CKD were those 
recommended for individuals with normal renal 
function. Over dosing may cause drug accumulation 
which increases the risk of adverse events and cost of 
treatment. The cost increases as a direct consequence of 
the additional doses which ought not to be 
administered and also increased hospital stay and 
interventions to manage the adverse drug events 
(Bonapaceet al 2002). 
Severity of renal disease had an inverse relationship 
with the probability of correct dosing. This poses a 
challenge because patients with severe loss of renal 
function are particular at risk of drug accumulation. In 
mild disease, the doses used in normal subjects may be 
appropriate, thus lessening the need for dose reduction. 
The only patient factor that had an effect on appropriate 
dosing was age.  Patients aged below 45 years were less 
likely to get an appropriate doses compared to older 
patients (adjusted OR 0.422 [95% CI: 0.198, 0.898]). 
This could probably be attributed to the fact that 
prescribers were more likely to pay greater attention to 
older patients were may be sicker. 
Drug characteristics such as the type of antibiotic, its 
duration and frequency of administration were 
significant determinants of appropriateness of the 
prescribed dose. Vancomycin was the only drug for 
which more than half the prescribed doses were 
appropriate. Out of the 48 prescriptions of vancomycin 
(Table 3), 33 required dose adjustment and 23 (69.7%) 
were appropriate dose.  Though empiric doses of 1g 
every 4-7 days were prescribed for most patients, it was 
difficult to ascertain if the doses were adequate because 
therapeutic drug monitoring (TDM) is not routinely 
done in hospital. Therapeutic drug monitoring (TDM), 
which is not routinely done in the referral, is required 
for drugs such as vancomycin. The need for TDM to 
guide vancomycin dosing has been studied and shown 
to be essential for proper management of serious 
infections in CKD patients (Ye et al, 2013).  
The other antibiotics for which the odds of receiving a 
correct dose were greater than that of benzylpenicillin 
were: ceftazidime; meropenem; imipenem/cilastatin; 
metronidazole and gentamicin. The nephrotoxicity of 
gentamicin is well known and this could have 
contributed to the tendency to prescribe correct doses. 
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In the case of ceftazidime, imipenem/cilastatin and 
meropenem, prescribers probably had good knowledge 
of the potential adverse consequences of inappropriate 
dosing in renal insufficiency. 
Drug were prescribed at a high frequency per day 
(adjusted OR 1.724 [95% CI: 1.185, 2.508]) were more 
likely to be prescribed appropriately.  This could be 
attributed to the fact that prescribers were more 
cautious about the risks of accumulation and adjusted 
the dose appropriately.  
Most patients treated with the older penicillins, such as 
amoxcyllin, benzylpenillin and amoxycillin-clavulanic 
acid received inappropriate doses. Penicillins have very 
wide therapeutic index and are may perceived by most 
prescribers to be safe. This could have promoted the 
tendency to neglect dose adjustment the doses in renal 
disease. Only 11(8.5%) out of 129 cases that required 
dose adjustment, received the appropriate dose of 
amoxycillin-clavulanic acid.  All patients treated with 
amoxicillin received inappropriate doses. The 
pharmacokinetic profile of amoxicillin-clavulanic acid is 
altered in patients with renal disease (Horber et al, 
1986) and there is likelihood of accumulation in CKD.  
Accumulation may lead to crystalluria (Labriola et al, 
2003).  
Strategies to alert prescribers of the need for dose 
adjustment should be considered. These strategies may 
include simplified aids to guide dose adjustment, 
automated systems for computation of GFR and 
adjustments to treatment sheets to highlight 
information on renal parameters. 
One of the limitations of the study was data on 
prescriber traits was not collected.  Consequently, it 
was not possible to determine the effect of prescriber 
traits on appropriate dose selection in patients with 
CKD.  Secondly, GFR was calculated using the MDRD 
equation but not the gold standard which requires use 
of an exogenous filtration marker (National Kidney 
Foundation, 2002). Furthermore, the study was 
retrospective in nature and therefore the information 
obtained from the records could not be verified. 
5. Conclusion 
Antibiotic dose adjustment in patients with CKD was 
often not done appropriately. This highlights the need 
to study barriers to dose adjustment to inform the 
design of interventions to promote safe prescribing.  
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